Related News
New Alzheimer's target a Notch above the rest?
Scientists have discovered a new potential target for Alzheimer's drugs that could reduce symptoms of the disease without interfering with other crucial bodily processes.
Association study of Notch 4 polymorphisms with Alzheimer’s ...
Lambert, J-C; Mann, D; Harris, J; Araria-Goumidi, L; Chartier-Harlin, M-C; Cottel, D; Iwatsubo, T; Amouyel, P; Lendon, C
Presenilin, Notch, and the genesis and treatment of Alzheimer's ...
Dennis J. Selkoe * Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, HIM 730, Boston, MA 02115
Notch signaling pathway - Wikipedia, the free encyclopedia
After this first cleavage, an enzyme called γ-secretase (which is implicated in Alzheimer's disease) cleaves the remaining part of the notch protein just inside the inner leaflet ...
Gamma-secretase/presenilin inhibitors for Alzheimer's disease ...
1. FASEB J. 2003 Jan;17(1):79-81. Epub 2002 Nov 1. Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila.
A common enzyme connects Notch signaling and Alzheimer's disease ...
Raphael Kopan 1 and Alison Goate; Department of Pharmacology and Molecular Biology, Departments of Psychiatry and Genetics, Washington University School of ...
Pharma Strategy Blog: Alzheimer's
We mentioned Lilly's agent, semagacestat, but as far as I know that is only being tested in Alzheimer's disease although they appear to be testing a NOTCH inhibitor in oncology ...
British Library Direct: Order Details
... complex and mutations in presenilins are the major cause of early-onset familial Alzheimer's disease. In addition to APP, g-secretase substrates include Notch1 homologues, Notch ...
{gamma}-Secretase/presenilin inhibitors for Alzheimer's disease ...
-Secretase/presenilin inhibitors for Alzheimer’s disease phenocopy Notch mutations in Drosophila 1 CRAIG A. MICCHELLI *, WILLIAM P. ESLER, W. TAYLOR KIMBERLY, CHRISTINE JACK, ...
Top-notch Alzheimer's residence will keep focus on the individual ...
Alzheimer's disease takes a $33 billion annual toll on American businesses in lost productivity by caregivers and related costs. And one diagnosis of Alzheimer's disease ...